These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 3792641

  • 21. Rabbit immunoglobulin responses to the flagella, somatic, and protective antigens of a highly protective strain of Clostridium chauvoei.
    Chandler HM.
    Infect Immun; 1975 Jul; 12(1):143-7. PubMed ID: 1170136
    [Abstract] [Full Text] [Related]

  • 22. An indirect hemagglutination test for the detection of antibodies to Clostridium chauvoei.
    Tamura Y, Makie H, Tanaka S.
    Vet Microbiol; 1985 Jun; 10(4):315-24. PubMed ID: 4035956
    [Abstract] [Full Text] [Related]

  • 23. Purification of a cross-protective antigen from Pasteurella multocida grown in vitro and in vivo.
    Rimler RB.
    Avian Dis; 2001 Jun; 45(3):572-80. PubMed ID: 11569729
    [Abstract] [Full Text] [Related]

  • 24. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A, van Straaten-van de Kappelle I, Hendriksen C, van de Donk H.
    Dev Biol Stand; 1996 Jun; 86():271-81. PubMed ID: 8785956
    [Abstract] [Full Text] [Related]

  • 25. [Isolation and identification in Senegal of the most immunogenic protein soluble antigen of a Clostridium chauvoei strain].
    Mbengue MB.
    Bull Soc Pathol Exot; 2008 Feb; 101(1):3-4. PubMed ID: 18431995
    [Abstract] [Full Text] [Related]

  • 26. The protective antigenicity of protoplasts and sphaeroplasts of a highly protective strain of Clostridium chauvoei.
    Chandler HM, Hamilton RC.
    J Gen Microbiol; 1975 May; 88(1):179-83. PubMed ID: 1151332
    [No Abstract] [Full Text] [Related]

  • 27. The use and standardization of multicomponent veterinary vaccines.
    Walker PD, Batty I.
    Dev Biol Stand; 1986 May; 65():227-36. PubMed ID: 3549398
    [Abstract] [Full Text] [Related]

  • 28. Antigen beads: a novel approach for the delivery of a soluble Anaplasma immunogen.
    James MA, Coronado A, Melendez RD, Ristic M.
    Am J Vet Res; 1984 Oct; 45(10):2123-5. PubMed ID: 6388435
    [Abstract] [Full Text] [Related]

  • 29. Purification and immunochemical properties of a wall protein antigen from Clostridium difficile ATCC 11011.
    Takumi K, Takeoka A, Kawata T.
    Microbiol Immunol; 1987 Oct; 31(9):837-49. PubMed ID: 3320689
    [Abstract] [Full Text] [Related]

  • 30. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK, Siber GR.
    Dev Biol Stand; 1996 Oct; 86():207-15. PubMed ID: 8785950
    [Abstract] [Full Text] [Related]

  • 31. Identifying and purifying protective immunogens from cultures of Clostridium chauvoei.
    Hauer PJ, Rosenbusch RF.
    Dev Biol Stand; 1996 Oct; 86():332. PubMed ID: 8785972
    [No Abstract] [Full Text] [Related]

  • 32. USDA: progress toward in vitro tests and other trends.
    Goodman SA.
    Dev Biol Stand; 1996 Oct; 86():41-7. PubMed ID: 8785990
    [Abstract] [Full Text] [Related]

  • 33. Mass production and standardization of Clostridium oedematiens vaccine against black disease (infectious necrotic hepatitis) of sheep.
    Ardehali M, Darakhshan H, Moosawi M.
    Dev Biol Stand; 1986 Oct; 64():137-40. PubMed ID: 3792643
    [Abstract] [Full Text] [Related]

  • 34. Responses of hamsters and guinea pigs to antigens of Clostridium chauvoei.
    Macheak ME, Claus KD.
    Am J Vet Res; 1972 May; 33(5):1039-44. PubMed ID: 5023041
    [No Abstract] [Full Text] [Related]

  • 35. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K, Gottschaldt J, Schulze F, Werner E, Erler W, Borrmann E.
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis.
    Rhie GE, Park YM, Han JS, Yu JY, Seong WK, Oh HB.
    FEMS Immunol Med Microbiol; 2005 Aug 01; 45(2):341-7. PubMed ID: 16019195
    [Abstract] [Full Text] [Related]

  • 37. [Immune response in mice challenged with extracts of Clostridium chauvoei].
    de Guzmán AM, Micalizzi B, Torres Pagano CE, Giménez DF.
    Rev Latinoam Microbiol; 1986 Aug 01; 28(2):121-5. PubMed ID: 3797862
    [No Abstract] [Full Text] [Related]

  • 38. Partial purification of cross-protection factor(s) from Pasteurella multocida.
    Rimler RB.
    Avian Dis; 1994 Aug 01; 38(4):778-89. PubMed ID: 7702511
    [Abstract] [Full Text] [Related]

  • 39. In vitro methods for vaccine evaluation.
    Reitan LJ, Secombes CJ.
    Dev Biol Stand; 1997 Aug 01; 90():293-301. PubMed ID: 9270857
    [Abstract] [Full Text] [Related]

  • 40. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep.
    Macheak ME, Claus KD, Maloy SE.
    Am J Vet Res; 1972 Jun 01; 33(6):1201-8. PubMed ID: 5022400
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.